Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background Dyslipidaemia may account for increased risk of cardiovascular disease in central obesity. Pharmacotherapy is often indicated in these patients, but the optimal approach remains unclear. We investigated the effects of atorvastatin and fish oil on plasma lipid and lipoprotein levels, including remnant‐like particle‐cholesterol and apolipoprotein C‐III, in dyslipidaemic men with visceral obesity. Methods We carried out a 6‐week randomized, placebo‐controlled, 2 × 2 factorial intervention study of atorvastatin (40 mg day−1) and fish oil (4 g day−1) on plasma lipids and lipoproteins in 52 obese men (age 53 1 years, BMI 33·7 0·55 kg m−2) with dyslipidaemia and insulin resistance. Treatment effects were analysed by general linear modelling. Results Atorvastatin had significant main effects in decreasing triglycerides (−0·38 0·02 mmol L−1, P = 0·002), total cholesterol (−1·89 0·17 mmol L−1, P = 0·001), LDL‐cholesterol (−1·78 0·14 mmol L−1, P = 0·001), remnant‐like particle‐cholesterol (−0·08 0·04 mmol L−1, P = 0·035), apolipoprotein B (−49 4 mg dL−1, P = 0·001), apolipoprotein C‐III (−12·6 6·1 mg L−1, P = 0·044) and in increasing HDL‐cholesterol (+0·10 0·04 mmol L−1, P = 0·007). Fish oil had significant main effects in decreasing triglycerides (−0·38 0·11 mmol L−1, P = 0·002) and in increasing HDL‐cholesterol (+0·07 0·04 mmol L−1, P = 0·041). There were no significant changes in weight or insulin resistance during the study. Conclusions Atorvastatin and fish oil have independent and additive effects in correcting dyslipidaemia in viscerally obese men. Improvement in abnormalities in remnant lipoproteins may occur only with use of atorvastatin. Combination treatment with statin and fish oil may, however, offer an optimal therapeutic approach for globally correcting dyslipidaemia in obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
(2001) · European Heart Journal · doi:10.1053/euhj.2001.2610 · Cited by 893
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
Self-citationComparison of statins in hypertriglyceridemia
Stein, E. A., Lane, M., & Laskarzewski, P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00041-1 · Cited by 386
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
Safety and efficacy of Omacor in severe hypertriglyceridemia
Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252
Cited by
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556
Calder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.001 · Cited by 488
Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.018 · Cited by 385
Fatty Acid Regulation of Gene Transcription
Jump, D. B. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490278341 · Cited by 356
Metadata
- Authors
- Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Beilin, L. J., & Redgrave, T. G.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 32
- Issue
- 6
- Pages
- 429-436
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2007080140
- Cited by
- 92
- References
- 12
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. https://app.cochat.ai/papers/10.1046/j.1365-2362.2002.01001.x
- The paper
- Chan, D. C., Watts, G. F., Mori, T. A., Barrett, P. H. R., Beilin, L. J., & Redgrave, T. G. (2002). Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.2002.01001.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.